Data Sciences Institute - Industry Speaker Series

Description

Melissa R. Miller, PhD, is a Senior Director of Human Genetics in the Internal Medicine Research Unit at Pfizer. Melissa and her team use human genetics and statistical genetics methods to help identify and prioritize targets to support the discovery of new medicines to address unmet medical needs in cardiovascular and metabolic diseases. Melissa leads or has been involved in several pre-competitive consortia including co-founding the UK Biobank Pharma Proteomics Consortium, the UK Biobank whole exome sequencing consortium, co-chair of the AMP Common Metabolic diseases program, and member of the Accelerating Medicines Partnership (AMP) Type 2 Diabetes (T2D). Melissa joined Pfizer in 2014. Prior to joining Pfizer, Melissa completed her PhD in Epidemiology at the University of Colorado and completed a post-doctoral fellowship in statistical genetics and genetic epidemiology at the Hospital for Sick Children in Toronto. Step into the future of data science with the DSI Industry Speaker Series. This dynamic series brings leaders from across industries to the University of Toronto’s Data Sciences Institute to share real-world challenges, innovative applications, and bold ideas shaping the data-driven world. Each session opens a window into how data science transforms sectors—from healthcare and finance to technology and beyond—while creating space for conversation, learning, and collaboration between industry and academia. Explore upcoming talks below and join us to connect, discover, and be inspired. For more information, please visit: https://datasciences.utoronto.ca/industry_speakers/.